Coccidioidomycosis Clinical Trial
Official title:
Safety, Sensitivity and Specificity of Spherule-derived Coccidioidin in Naive Adults, in Adults With a History of Pulmonary Coccidioidomycosis and in Adults With a History of Pulmonary Histoplasmosis
Adult volunteers were skin tested with 1.27 ug spherule-derived coccidioidin. The skin test antigen was evaluated in three different populations of adult volunteers to determine the safety and efficacy of the product in the assessment of delayed-type hypersensitivity to Coccidioides immitis. Induration greater than or equal to 5 mm after 48 hours was considered positive for exposure to C. immitis.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Diagnostic
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04208321 -
Safety and Pharmacokinetics of VT-1598
|
Phase 1 | |
| Terminated |
NCT00614666 -
Safety and PK of Nikkomycin Z for Coccidioides Pneumonia Treatment
|
Phase 1/Phase 2 | |
| Recruiting |
NCT02190266 -
Pathogenesis and Genetics of Disseminated or Refractory Coccidioidomycosis
|
||
| Completed |
NCT00796809 -
Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis
|
N/A | |
| Withdrawn |
NCT02908334 -
Sertraline in Addition to Standard of Care Treatment for Coccidioidomycosis
|
Phase 2 | |
| Completed |
NCT00423267 -
POS vs FLU for First Line Treatment of Coccidioidomycosis (Study P04558Am1)(COMPLETED)
|
Phase 3 | |
| Withdrawn |
NCT04809649 -
SUBA-Itraconazole Therapy for Coccidioidomycosis Refractory or Intolerant to Fluconazole
|
Phase 2 | |
| Completed |
NCT03908632 -
An Observational Study to Assess the Prevalence and Outcomes of Primary Pulmonary Coccidioidomycosis in Persons Aged > / = 14 Years Presenting With Community Acquired Pneumonia (CAP) in Endemic Areas (SAnds-PPC)
|
||
| Terminated |
NCT02663674 -
Efficacy Study of Fluconazole to Treat Coccidioidomycosis Pneumonia (Valley Fever)
|
Phase 4 | |
| Terminated |
NCT03618992 -
Improving the Appearance of Skin and Hair in Patients Undergoing Valley Fever Treatment
|
N/A | |
| Completed |
NCT03059992 -
Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment
|
Phase 3 | |
| Completed |
NCT00002325 -
A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common
|
N/A |